Pridopidine for treating drug induced dyskinesias
AssigneePrilenia Neurotherapeutics Ltd.
InventorsMichal GEVA, Aric Orbach, Michael Hayden
Life of this patent
Estimating the term…
Abstract
The invention provides a method of treating a subject afflicted with a drug-induced movement disorder including levodopa-induced dyskinesia comprising periodically administering to the subject in need thereof an amount of pridopidine or pharmaceutically acceptable salt thereof effective to treat the subject. The invention further provides a method of treating a subject at risk of developing a drug-induced movement disorder, including levodopa-induced dyskinesia
Claims29
A method of treating levodopa-induced dyskinesia (LID) in a subject in need thereof, comprising a combination therapy of administering to the subject pridopidine or pharmaceutically acceptable salt thereof, and amantadine.
Dependencies are inferred from the claim text.